Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8895744 Alfa-carboline inhibitors of NPM-ALK, RET, and Bcr-Abl

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
August 27, 2009
Date of Patent
November 25, 2014
Patent Application Number
13062665
Patent Citations Received
‌
US Patent 11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
0
‌
US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors
0
‌
US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors
0
Patent Inventor Names
Benoit Joseph
0
Carlo Gambacorti Passerini
0
Cedric Schneider
0
David Gueyrard
0
Florence Popowycz
0
Leonardo Scapozza
0
Luca Mologni
0
Peter G. Goekjian
0
Pierre Garcia
0
Shaheen Ahmed
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8895744
Patent Primary Examiner
‌
Heidi Reese

Find more entities like US Patent 8895744 Alfa-carboline inhibitors of NPM-ALK, RET, and Bcr-Abl

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo